DK98884A - Human beta-nervevaekstfaktor og fremg. til fremst. deraf, dna-sekvens, som koder for faktoren, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farma. praeparat og anven. af faktoren til behand. af beskadigede nerver - Google Patents
Human beta-nervevaekstfaktor og fremg. til fremst. deraf, dna-sekvens, som koder for faktoren, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farma. praeparat og anven. af faktoren til behand. af beskadigede nerver Download PDFInfo
- Publication number
- DK98884A DK98884A DK98884A DK98884A DK98884A DK 98884 A DK98884 A DK 98884A DK 98884 A DK98884 A DK 98884A DK 98884 A DK98884 A DK 98884A DK 98884 A DK98884 A DK 98884A
- Authority
- DK
- Denmark
- Prior art keywords
- factor
- dna sequence
- vector
- recombinant
- farma
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title 2
- 101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 239000003102 growth factor Substances 0.000 title 1
- 102000055647 human CSF2RB Human genes 0.000 title 1
- 210000005036 nerve Anatomy 0.000 title 1
- FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 102000015336 Nerve Growth Factor Human genes 0.000 abstract 1
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 229940053128 nerve growth factor Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47196283A | 1983-03-03 | 1983-03-03 | |
US47196283 | 1983-03-03 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK98884D0 DK98884D0 (da) | 1984-02-24 |
DK98884A true DK98884A (da) | 1984-10-04 |
DK161152B DK161152B (da) | 1991-06-03 |
DK161152C DK161152C (da) | 1991-11-11 |
Family
ID=23873671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK098884A DK161152C (da) | 1983-03-03 | 1984-02-24 | Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0121338B2 (da) |
JP (4) | JPS6084299A (da) |
KR (1) | KR840008026A (da) |
AT (1) | ATE45382T1 (da) |
AU (1) | AU574350B2 (da) |
CA (1) | CA1220736A (da) |
DE (1) | DE3479321D1 (da) |
DK (1) | DK161152C (da) |
ES (1) | ES8600783A1 (da) |
IE (1) | IE57013B1 (da) |
NZ (1) | NZ207337A (da) |
ZA (1) | ZA841597B (da) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0789936B2 (ja) * | 1985-09-12 | 1995-10-04 | サイオス ノバ インコーポレイテッド | 組換え繊維芽細胞成長因子 |
JPH01102096A (ja) * | 1987-10-15 | 1989-04-19 | Sanwa Kagaku Kenkyusho Co Ltd | モチリン様活性を有するポリペプチド、その発現用微生物及び該ポリペプチドの製法 |
JPH01211490A (ja) * | 1988-02-19 | 1989-08-24 | Tosoh Corp | ヒト神経成長因子遺伝子セグメント |
IT1219874B (it) * | 1988-03-18 | 1990-05-24 | Fidia Farmaceutici | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche |
US5134121A (en) * | 1988-03-28 | 1992-07-28 | Regents Of The University Of California | Nerve growth factor peptides |
US5683894A (en) * | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
JPH0771509B2 (ja) * | 1988-07-12 | 1995-08-02 | 工業技術院長 | ヒトβ−NGFの発現法 |
US5082774A (en) * | 1988-08-30 | 1992-01-21 | The General Hospital Corporation | Recombinant human nerve growth factor |
US5272063A (en) * | 1988-11-22 | 1993-12-21 | Syntex (U.S.A.) Inc. | Process of making human nerve growth factor |
US6709837B1 (en) * | 1989-03-10 | 2004-03-23 | Takeda Chemical Industries, Inc. | Polypeptide and production thereof |
SE8901715L (sv) * | 1989-05-12 | 1990-11-13 | Lope Medicine Ab | En plasmid dna-konstruktion innehaallande dna-sekvenser |
IT1232157B (it) * | 1989-07-20 | 1992-01-25 | Fidia Farmaceutici | Purificazione del fattore di crescita nervoso tramite cromatografia a scambio di subunita' |
DK0414151T3 (da) * | 1989-08-21 | 1995-05-22 | Takeda Chemical Industries Ltd | Humane nervevæskstfaktorproteiner og fremstilling deraf |
US5656435A (en) * | 1989-08-28 | 1997-08-12 | Takeda Chemical Industries, Ltd. | Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof |
US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
US6933276B1 (en) | 1989-08-30 | 2005-08-23 | Regeneron Pharmaceuticals, Inc. | Methods of treating peripheral neuropathies using neurotrophin-3 |
IL95511A (en) | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
IT1238348B (it) * | 1989-11-16 | 1993-07-13 | Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote. | |
JPH03244385A (ja) * | 1990-02-21 | 1991-10-31 | Hitachi Ltd | ヒト神経成長因子の遺伝子工学的生産方法 |
IT1239271B (it) * | 1990-02-27 | 1993-10-01 | Fidia Spa | Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante |
US5235043A (en) * | 1990-04-06 | 1993-08-10 | Synergen, Inc. | Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
US5606031A (en) * | 1990-04-06 | 1997-02-25 | Lile; Jack | Production and purification of biologically active recombinant neurotrophic protein in bacteria |
US5986070A (en) * | 1990-04-06 | 1999-11-16 | Amgen Inc. | Production of biologically active NGF proteins |
US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
NZ243084A (en) * | 1991-06-12 | 1995-08-28 | Regeneron Pharma | Production and recovery of recombinant neurotrophins, genes for a modified lamb signal sequence, fusion genes and plasmids |
DE4139000A1 (de) | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf |
US6063757A (en) * | 1995-11-29 | 2000-05-16 | Urso; Richard G. | Wound treatment method with nerve growth factor |
JP4108755B2 (ja) * | 1996-09-11 | 2008-06-25 | 大日本住友製薬株式会社 | 新規セマフォリン遺伝子:セマフォリンy |
WO1998021234A2 (en) | 1996-11-15 | 1998-05-22 | Genentech, Inc. | Purification of neurotrophins |
AU5734298A (en) * | 1997-02-06 | 1998-08-26 | Aventis Pharmaceuticals Inc. | Human nerve growth factor exon 1 and exon 3 promoters |
US6197551B1 (en) * | 1998-01-27 | 2001-03-06 | Millennium Pharmaceuticals, Inc. | Spoil-1 protein and nucleic acid molecules and uses therefor |
ITRM20050045A1 (it) * | 2005-02-02 | 2006-08-03 | Consiglio Nazionale Ricerche | Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi. |
US7300691B2 (en) | 2005-09-27 | 2007-11-27 | Milliken & Company | Moldable construction incorporating non-olefin bonding interface |
US7294384B2 (en) | 2005-09-27 | 2007-11-13 | Milliken & Company | Moldable construction incorporating bonding interface |
US7378359B2 (en) | 2005-09-27 | 2008-05-27 | Eleazer Howell B | Moldable fibrous construction incorporating non-woven layers |
US20080124513A1 (en) | 2006-09-11 | 2008-05-29 | Eleazer Howell B | Moldable fabric with unidirectional tape yarns |
JP6767688B2 (ja) | 2015-05-20 | 2020-10-14 | パナソニックIpマネジメント株式会社 | 室内空調システム |
IT202000005542A1 (it) | 2020-03-16 | 2021-09-16 | Themis S R L | Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4185095A (en) | 1977-11-23 | 1980-01-22 | The Massachusetts General Hospital | Nerve growth factor |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
-
1984
- 1984-02-24 DK DK098884A patent/DK161152C/da not_active IP Right Cessation
- 1984-03-01 IE IE493/84A patent/IE57013B1/en not_active IP Right Cessation
- 1984-03-01 ES ES530202A patent/ES8600783A1/es not_active Expired
- 1984-03-01 NZ NZ207337A patent/NZ207337A/en unknown
- 1984-03-02 CA CA000448766A patent/CA1220736A/en not_active Expired
- 1984-03-02 AU AU25252/84A patent/AU574350B2/en not_active Expired
- 1984-03-02 EP EP84301377A patent/EP0121338B2/en not_active Expired - Lifetime
- 1984-03-02 KR KR1019840001051A patent/KR840008026A/ko not_active Application Discontinuation
- 1984-03-02 DE DE8484301377T patent/DE3479321D1/de not_active Expired
- 1984-03-02 JP JP59041205A patent/JPS6084299A/ja active Granted
- 1984-03-02 AT AT84301377T patent/ATE45382T1/de not_active IP Right Cessation
- 1984-03-02 ZA ZA841597A patent/ZA841597B/xx unknown
-
1992
- 1992-07-13 JP JP4185044A patent/JP2740417B2/ja not_active Expired - Lifetime
- 1992-12-25 JP JP4346116A patent/JP2898494B2/ja not_active Expired - Lifetime
- 1992-12-25 JP JP4346109A patent/JPH067169A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK161152B (da) | 1991-06-03 |
JPS6084299A (ja) | 1985-05-13 |
IE840493L (en) | 1984-09-03 |
KR840008026A (ko) | 1984-12-12 |
AU574350B2 (en) | 1988-07-07 |
EP0121338A1 (en) | 1984-10-10 |
JP2898494B2 (ja) | 1999-06-02 |
ES530202A0 (es) | 1985-11-01 |
EP0121338B1 (en) | 1989-08-09 |
AU2525284A (en) | 1984-09-06 |
EP0121338B2 (en) | 1999-10-27 |
JPH067169A (ja) | 1994-01-18 |
IE57013B1 (en) | 1992-03-11 |
NZ207337A (en) | 1987-11-27 |
DK161152C (da) | 1991-11-11 |
JPH0690764A (ja) | 1994-04-05 |
DK98884D0 (da) | 1984-02-24 |
JP2740417B2 (ja) | 1998-04-15 |
ZA841597B (en) | 1984-10-31 |
ES8600783A1 (es) | 1985-11-01 |
JPH05310792A (ja) | 1993-11-22 |
CA1220736A (en) | 1987-04-21 |
ATE45382T1 (de) | 1989-08-15 |
JPH0536031B2 (da) | 1993-05-28 |
DE3479321D1 (en) | 1989-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK98884D0 (da) | Human beta-nervevaekstfaktor og fremg. til fremst. deraf, dna-sekvens, som koder for faktoren, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farma. praeparat og anven. af faktoren til behand. af beskadigede nerver | |
DK144695A (da) | Ekspressionsvektor eller et par af ekspressionsvektorer omfattende heterolog DNA, som koder for alfa- og beta-underenhederne af humant FSH, eukatyotisk celle transficeret med vektoren eller parret af vektorer, fremgangsmåde til fremstilling af biologisk aktivt heterodimert humant FSH og fremgangsmåde til fremstilling af et farmaceutisk præparat indeholdende rekombinant humant FSH | |
NO166943C (no) | Analogifremgangsmaate for fremstilling av enzymresistente immunomodulerende peptider. | |
DK198883A (da) | Fremgangsmaade til fremstilling af menneskevaevs-plasminogen-aktivator, dna-sekvens der koder for denne aktivator, replicerbar udtrykkelsesvektor for dna-sekvensen og mikroorganisme eller cellekultur transformeret med udtrykkelsesvektoren | |
DK224587D0 (da) | Ekstracellulaer superoxiddismutase (ec-sod), dna-fragment, der indkoder ec-sod, fremgangsmaade til fremstilling af ec-sod samt anvendelse af ec-sod | |
EP0272779A3 (en) | New forms of colony stimulating factor-1 | |
IT8484131A0 (it) | Procedimento per la produzione di ossigeno mediante apparecchiatura portatile, particolarmente per respirazione umana, ed apparecchiatura per attuare il procedimento. | |
DK623587D0 (da) | Plantevaekstregulerende middel og anvendelse af dette til regulering af plantevaekst | |
IT1206292B (it) | Elettrodi durevoli per elettrolisi e procedimento per produrli | |
ES8704547A1 (es) | Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion. | |
ES2026206T3 (es) | Procedimiento para mejorar la expresion de proteina de eucariota. | |
PT83733B (pt) | Processo para a preparacao de tiozolonas com actividade cardiotonica | |
DK179384D0 (da) | Interferon og interferoninducere kombineret med tobaksprodukter | |
DK489086A (da) | Tetradecapeptider med mitogen aktivitet og fremgangsmaade til stimulering af vaeksten af macrophag-lignende celler | |
ES538454A0 (es) | Procedimiento para preparar protoplastos de talos de ovas | |
DK100785D0 (da) | Midler til stimulering af haarvaekst | |
DK129184D0 (da) | Fremgangsmaade til regulering af stroemmen i et anlaeg til elektrolytisk vandbehandling | |
SU1031367A1 (ru) | Способ обработки структур кремний-двуокись кремния | |
ES8703928A1 (es) | Un metodo para preparar la proteina factor de estimulacion de colonias (csf-1)recombinante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |